Brief: Neurovive Pharmaceutical Q2 Loss Before Tax Widens To SEK 25.5 Mln

Abliva AB

21/08/2018 07:32

Aug 21 (Reuters) - NeuroVive Pharmaceutical AB  NVP.ST :
    * Q2 LOSS BEFORE TAX: SEK -25,481,000 (-22,256,000)
    * Q2 NET REVENUES: SEK 0 (0)

Source text for Eikon:  ID:nWkr7NRZ11 
Further company coverage:  NVP.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))